🤖 AI Summary
To address the high resource consumption, procedural risks, and diagnostic delays associated with invasive coronary angiography in acute coronary syndrome (ACS) diagnosis, this study proposes a non-invasive multimodal predictive framework. The method fuses echocardiographic video sequences with structured clinical records, leveraging a tabular-guided cross-modal attention mechanism and a late-fusion architecture to predict therapeutic interventions non-invasively. Its key innovations include (i) using structured clinical tabular data to guide visual–textual cross-modal interaction, and (ii) designing a multi-source medical data alignment strategy to harmonize heterogeneous inputs. Evaluated on over 9,000 real-world ACS cases, the model achieves a balanced accuracy of 67.6%, an AUROC of 71.1%, and 88.6% consistency in cross-modal intervention prediction—demonstrating substantial improvements in triage efficiency and clinical decision reliability, particularly in resource-constrained settings.
📝 Abstract
Coronary angiography remains the gold standard for diagnosing Acute Coronary Syndrome (ACS). However, its resource-intensive and invasive nature can expose patients to procedural risks and diagnostic delays, leading to postponed treatment initiation. In this work, we introduce TREAT-Net, a multimodal deep learning framework for ACS treatment prediction that leverages non-invasive modalities, including echocardiography videos and structured clinical records. TREAT-Net integrates tabular-guided cross-attention to enhance video interpretation, along with a late fusion mechanism to align predictions across modalities. Trained on a dataset of over 9000 ACS cases, the model outperforms unimodal and non-fused baselines, achieving a balanced accuracy of 67.6% and an AUROC of 71.1%. Cross-modality agreement analysis demonstrates 88.6% accuracy for intervention prediction. These findings highlight the potential of TREAT-Net as a non-invasive tool for timely and accurate patient triage, particularly in underserved populations with limited access to coronary angiography.